Related Experiment Video
Updated: Jan 13, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States
Background:
Atopic dermatitis (AD) disproportionately affects diverse patient populations, and complex factors influence access to treatment among different racial and ethnic groups.
Objective:
This study aimed to assess racial and ethnic differences in AD severity and access to treatment in clinical practice.
Methods:
The study included patients aged 6 and older with AD enrolled in TARGET-DERM AD, an observational, longitudinal study utilizing electronic medical records from 43 academic and community centers across the United States.
Results:
The analysis included 1,928 participants: 577 children (30%) and 1,351 adults (70%), with 42% identifying as Non-White. Non-Hispanic (NH) Asian participants exhibited the highest percentage of moderate-to-severe AD at 63%, followed by NH-Black (61%), Hispanic (49%), and NH-White (48%) participants. Over half (56%) of NH-Asian patients reported comorbid asthma. NH-Black and Hispanic individuals were less likely to receive advanced systemic therapies compared to NH-White individuals, with odds ratios of 0.71 and 0.66, respectively, both statistically significant (P<0.01).
Conclusion:
Despite having moderate-to-severe AD, NH-Black and Hispanic patients had significantly lower odds of receiving advanced systemic therapy compared to NH-White patients, highlighting potential disparities in access to advanced treatments for AD.  .
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
iPS Cell Differentiation
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Clinical Applications of Epidermal Stem Cells

